ATTRUBY FDA approval date

The FDA approved ATTRUBY on 22 Nov 2024.

FDA approval date
22 Nov 2024

Drug identity has not yet been verified against registry records

Also recorded as ACORAMIDIS HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-11-22DayATTRUBYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216540", "applicant_as_listed_by_fda": "BRIDGEBIO PHARMA", "brand_names": ["ATTRUBY"], "active_ingredients": ["ACORAMIDIS HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20241122", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026